Causal Inference of CNS-regulated Hormones in COVID-19: A Bidirectional Two-sample Mendelian Randomization Study

Abstract

Objectives: We assessed the causal association of three COVID-19 phenotypes with insulin-like growth factor 1 (IGF-1), estrogen, testosterone, dehydroepiandrosterone (DHEA), thyroid-stimulating hormone (TSH), thyrotropin-releasing hormone (TRH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Methods: We used a bidirectional two-sample univariate and multivariable Mendelian randomization (MR) analysis to evaluate the direction, specificity, and causality of the association between CNS-regulated hormones and COVID-19 phenotypes. Genetic instruments for CNS-regulated hormones were selected from the largest publicly available genome-wide association studies in the European population. Summary-level data on COVID-19 severity, hospitalization, and susceptibility were obtained from the COVID-19 host genetic initiative. Results: DHEA was associated with increased risks of very severe respiratory syndrome (OR=4.21, 95% CI: 1.41-12.59), consistent with the results in multivariate MR (OR=3.72, 95% CI: 1.20-11.51), and hospitalization (OR = 2.31, 95% CI: 1.13-4.72) in univariate MR. LH was associated with very severe respiratory syndrome (OR=0.83; 95% CI: 0.71-0.96) in univariate MR. Estrogen was negatively associated with very severe respiratory syndrome (OR=0.09, 95% CI: 0.02-0.51), hospitalization (OR=0.25, 95% CI: 0.08-0.78), and susceptibility (OR=0.50, 95% CI: 0.28-0.89) in multivariate MR. Conclusions: We found strong evidence for the causal relationship of DHEA, LH, and estrogen with COVID-19 phenotypes.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study is supported by the Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University (Grant No. 392016).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The source data were openly available before the study conducted and could be found as following: GWAS summary data of seven hormone traits are available in IEU open GWAS project (https://gwas.mrcieu.ac.uk/). GWAS summary data of TSH are collected in a GWAS meta-analysis of thyroid-related traits. Summary statistics (release 5) of GWAS meta-analysis for the three COVID-19 phenotypes are available in the COVID-19 Host Genetics Initiative (HGI) at https://www.covid19hg.org/results/r5/.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

GWAS summary data of seven hormone traits are available in IEU open GWAS project (https://gwas.mrcieu.ac.uk/) with GWAS ID as ukb-d-30770_irnt for IGF-1, ukb-d-30800_irnt for Estradiol, ukb-d-30850_irnt for Testosterone, met-a-478 for DHEA-S, prot-a-3102 for TRH, prot-a-529 for LH, and prot-c-3032_11_2 for FSH. GWAS summary data of TSH are collected in a GWAS meta-analysis of thyroid-related traits. Summary statistics (release 5) of GWAS meta-analysis for the three COVID-19 phenotypes are available in the COVID-19 Host Genetics Initiative (HGI) at https://www.covid19hg.org/results/r5/.

https://gwas.mrcieu.ac.uk/

留言 (0)

沒有登入
gif